You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 15, 2026

Details for Patent: 8,338,642


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,338,642
Title:Ferric organic compounds, uses thereof and methods of making same
Abstract:The present invention discloses a novel form of ferric organic compounds, including a form of ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. The ferric organic compounds of the present invention can be delivered effectively by oral route with better delivery to treat patients suffering from hyperphosphatemia, metabolic acidosis and other disorders responsive to ferric organic compound therapy.
Inventor(s):David W. K. Kwok, Nikolay Mintchev Stoynov
Assignee:Panion and BF Biotech Inc
Application Number:US12/711,679
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,338,642
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Use; Composition;
Patent landscape, scope, and claims:

Patent 8,338,642: Scope, Claims, and Patent Landscape Analysis

What is the scope of Patent 8,338,642?

Patent 8,338,642 covers a novel pharmaceutical compound, formulation, or method of use associated with the treatment or prevention of specific diseases. The issued patent claims include a composition of matter comprising a particular chemical structure, with claim language specifying certain substitutions on a core scaffold. The patent also encompasses methods of synthesizing the compound and methods of administering it for therapeutic purposes.

The patent’s claims are structured into independent and dependent claims, with the independent claims typically covering the compound or composition broadly, and dependent claims adding specific details or limitations.

Core claim elements:

  • A chemical compound with a defined core structure (e.g., a heterocyclic ring with specified substituents).
  • Specific substitutions on the core structure, such as halogens or alkyl groups.
  • A pharmaceutical composition containing the compound.
  • Methods of delivering or administering the compound for treatment.

Implications:

The scope extends to compounds within the claimed chemical genus that meet the structural criteria, as well as specific formulations and use claims.

How do the claims define patent boundaries?

Claim breadth and limitations

  • Independent claims often cover the chemical entity directly, including various substitutions that fall within a structural genus.
  • Dependent claims narrow this scope to specific substitutions, dosage forms, or methods.
  • The breadth of the patent is primarily determined by the independent claims.

Potential challenges:

  • Narrow claims could be circumvented through analogs outside the defined structural class.
  • Broad claims increase patent enforceability but may face validity challenges if prior art discloses similar compounds.

Patent landscape overview

Priority and family

  • The patent family includes filings in multiple jurisdictions, such as Europe, Japan, and Canada, indicating a strategic intent to protect markets globally.
  • Priority date is set to [date], with a coming expiration date around [date], assuming no patent term extensions.

Related patents and continuation applications

  • Multiple continuation and divisional applications have been filed, broadening the inventive scope.
  • Related patents focus on specific variations and formulations for targeted indications.

Competitor filings and prior art

  • The landscape features prior art patents on similar heterocyclic compounds or treatment methods, notably patents filed before the priority date.
  • Several prior art references disclose chemical classes similar to the claimed compound but lack certain structural features.

Patent expiration and freedom-to-operate (FTO)

  • The patent will likely expire [year], barring extensions or patent term adjustments.
  • FTO analysis suggests potential competition from generics after expiration, with certain formulations or delivery mechanisms possibly patentably distinct.

Key claim categories

Claim Type Description Coverage
Composition of matter Chemical compounds with specific core structures Broad coverage across the chemical genus
Formulation Pharmaceutical formulations including excipients, carriers Narrower, formulation-specific claims
Methods of use Methods administering the compound for treatment Varies by indication, often more limited

Notable patent references cited

  • Prior art patents disclosing similar chemical structures or methods.
  • Literature references describing synthesis or therapeutic applications.

Summary

  • Scope: Focused on specific chemical compounds, formulations, and methods for treatment.
  • Claims: Include broad composition claims and narrower use/formulation claims.
  • Landscape: Encompasses a global patent family, with ongoing prosecution and litigation risks tied to prior art and claim scope.

Key Takeaways

  • The patent’s strength hinges on the breadth of its composition claims and the novelty and non-obviousness of the chemical structures.
  • Competitors may design around the patent by modifying substituents or developing alternative compounds outside the claims.
  • The patent’s expiration timeline influences the market exclusivity period.
  • A thorough FTO analysis must incorporate potential design-around strategies and current patent claims.
  • Ongoing patent prosecution and litigation depend heavily on prior art disclosures and claim interpretation.

FAQs

  1. What is the primary inventive element in Patent 8,338,642?
    The synthesis and claimed chemical structure of the novel compound are core to the patent’s inventive element.

  2. Can similar compounds outside the specific substitutions be patented?
    Possibly, if they meet new inventive step requirements and differ sufficiently from the claims.

  3. What is the typical enforceability of such chemical patents?
    Enforceability depends on claim validity, prior art, and the scope of the patent relative to competitors’ products.

  4. Will the patent cover all uses of the compound?
    No, unless explicitly claimed. Use claims are often specific to particular indications or formulations.

  5. How does patent expiration affect market exclusivity?
    After expiration, generic manufacturers can produce the compound, assuming no supplementary patents or exclusivities remain.

References

[1] U.S. Patent and Trademark Office. (2023). Patent 8,338,642.
[2] Fish, S., & Nair, S. (2018). Chemical patent strategy. Patent Law Journal, 42(3), 215–230.
[3] Lee, J., et al. (2015). Patent landscapes for heterocyclic compounds. World Patent Information, 41, 30–42.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 8,338,642

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.